There is no product in the shopping cart, buy it!
Creative Biolabs has developed a range of glycopeptide products, including N-linked glycopeptides, O-linked glycopeptides, and glycated peptides.
With rich experience in Custom Glycopeptide Synthesis, we are committed to providing overall solutions according to every special need of our global clients. Our R&D scientific team has designed and completed hundreds of custom glycopeptide synthesis projects, including N-, O-, C-, and S-linked glycopeptide synthesis. Our experienced scientists are glad to apply this special expertise to help our clients with their cutting-edge glycopeptide projects.
If you are interested in our glycopeptide products and custom synthesis service, please feel free to contact us or directly send us an inquiry.
Cat | Product Name | Species | Target | Size | Datasheet | Inquiry |
---|---|---|---|---|---|---|
GLJF-0522-JF146 | CMV pp65 Glycopeptide (491-509)-[495: Man5-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF147 | CMV pp65 Glycopeptide (491-509)-[495: Man6-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF148 | CMV pp65 Glycopeptide (491-509)-[495: Man7-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF149 | CMV pp65 Glycopeptide (491-509)-[495: Man8-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF150 | CMV pp65 Glycopeptide (491-509)-[495: Man9-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF151 | CMV pp65 Glycopeptide (491-509)-[507: Asn(GlcNAc-β-D)] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF152 | CMV pp65 Glycopeptide (491-509)-[507: Man1-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF153 | CMV pp65 Glycopeptide (491-509)-[507: Man2-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF154 | CMV pp65 Glycopeptide (491-509)-[507: Man3-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF155 | CMV pp65 Glycopeptide (491-509)-[507: Man4-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF156 | CMV pp65 Glycopeptide (491-509)-[507: Man5-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF157 | CMV pp65 Glycopeptide (491-509)-[507: Man6-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF158 | CMV pp65 Glycopeptide (491-509)-[507: Man7-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF159 | CMV pp65 Glycopeptide (491-509)-[507: Man8-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF160 | CMV pp65 Glycopeptide (491-509)-[507: Man9-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF161 | CMV pp65 Glycopeptide (491-509)-[495, 507: Asn(GlcNAc-β-D)] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF162 | CMV pp65 Glycopeptide (491-509)-[495, 507: Man1-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF163 | CMV pp65 Glycopeptide (491-509)-[495, 507: Man2-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF164 | CMV pp65 Glycopeptide (491-509)-[495, 507: Man3-Asn] | Human cytomegalovirus (CMV) | pp65 | |||
GLJF-0522-JF165 | CMV pp65 Glycopeptide (491-509)-[495, 507: Man4-Asn] | Human cytomegalovirus (CMV) | pp65 |